Previous 10 | Next 10 |
MINNEAPOLIS and SAN RAFAEL, Calif., April 18, 2019 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”) today announced a services agreement between its wholly owned subsidiary, Helomics and the National Alopecia Areata Fo...
MINNEAPOLIS, April 16, 2019 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”) today announced that its wholly owned subsidiary, TumorGenesis, is participating with 48Hour Discovery (48HD), a Canadian partner, in receivi...
PITTSBURGH, April 11, 2019 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”) today announced that its wholly-owned subsidiary, Helomics® Corporation (Helomics), which provides personalized medicine solutions a...
PHOENIX, AZ / ACCESSWIRE / April 11, 2019 / Uptick Newswire Stock Day Podcast welcomed Precision Therapeutics Inc. (NASDAQ: AIPT ) ("the Company"), a company with business lines that include applying artificial intelligence to personalized medicine and drug discovery to provide personalized...
MINNEAPOLIS, April 09, 2019 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”) today announced a collaboration between its wholly owned subsidiary, Helomics, and Viome, a new kind of healthcare company transforming healt...
MINNEAPOLIS, April 05, 2019 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision Therapeutics” or “the Company”), today announced the completion of its merger with Helomics Holding Corporation (“ Helomics ”), which has become...
Precision Therapeutics Inc. (AIPT) Q4 2018 Earnings Conference Call April 01, 2019 16:30 P.M. ET Company Participants Scott Gordon - IR, CORE IR Dr. Carl Schwartz - President and CEO Bob Myers - CFO Jerry Vardzel - CEO, Helomics Corp Richard Gabriel - Board Member Conferen...
Precision Therapeutics (NASDAQ: AIPT ): FY GAAP EPS of -$0.79. More news on: Precision Therapeutics Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
MINNEAPOLIS, April 01, 2019 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence to Women’s Oncology, announced today financial results for the quarter and fisc...
Thinly traded nano cap Precision Therapeutics (NASDAQ: AIPT ) slips 9% premarket on modestly higher volume in reaction to its public offering of 1.5M units at $0.80 per unit on a "best efforts" basis. More news on: Precision Therapeutics Inc., Healthcare stocks news, Stocks o...
News, Short Squeeze, Breakout and More Instantly...
Precision Therapeutics Inc. Company Name:
AIPT Stock Symbol:
NASDAQ Market:
MINNEAPOLIS, June 12, 2019 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (Nasdaq: AIPT) (“Predictive Oncology” or the “Company”), a company focused on applying artificial intelligence to personalized medicine and drug discovery, announced today it has appointed Am...
MINNEAPOLIS, June 11, 2019 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (Nasdaq: AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence to personalized medicine and drug discovery, announced today that it has changed its co...
The global precision medicine market is expected to reach revenues of over $216.75 billion by 2028, propelled by a growing interest in personalized approaches to disease treatments and the application of new technologies Precision Therapeutics and its three wholly owned subdivisions are a...